151 related articles for article (PubMed ID: 30452907)
1. Comparison of different chemically modified inhibitors of miR-199b in vivo.
Duygu B; Juni R; Ottaviani L; Bitsch N; Wit JBM; de Windt LJ; da Costa Martins PA
Biochem Pharmacol; 2019 Jan; 159():106-115. PubMed ID: 30452907
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
[TBL] [Abstract][Full Text] [Related]
3. Silencing of microRNAs in vivo with 'antagomirs'.
Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
[TBL] [Abstract][Full Text] [Related]
4. miR-199b-5p is a regulator of left ventricular remodeling following myocardial infarction.
Duygu B; Poels EM; Juni R; Bitsch N; Ottaviani L; Olieslagers S; de Windt LJ; da Costa Martins PA
Noncoding RNA Res; 2017 Mar; 2(1):18-26. PubMed ID: 30159417
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S
Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368
[TBL] [Abstract][Full Text] [Related]
6. LNA-mediated microRNA silencing in non-human primates.
Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S
Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051
[TBL] [Abstract][Full Text] [Related]
7. RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.
Lee TJ; Yoo JY; Shu D; Li H; Zhang J; Yu JG; Jaime-Ramirez AC; Acunzo M; Romano G; Cui R; Sun HL; Luo Z; Old M; Kaur B; Guo P; Croce CM
Mol Ther; 2017 Jul; 25(7):1544-1555. PubMed ID: 28109960
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
[TBL] [Abstract][Full Text] [Related]
9. Control of oncogenic miRNA function by light-activated miRNA antagomirs.
Connelly CM; Deiters A
Methods Mol Biol; 2014; 1165():99-114. PubMed ID: 24839022
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAome in decidua: a new approach to assess the maintenance of pregnancy.
Wang Y; Lv Y; Wang L; Gong C; Sun J; Chen X; Chen Y; Yang L; Zhang Y; Yang X; Bai C; Wei Z; Li G
Fertil Steril; 2015 Apr; 103(4):980-989.e6. PubMed ID: 25747134
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of inhibition of miRNA expression induced by anti-miRNA oligonucleotides.
Chae DK; Ban E; Yoo YS; Baik JH; Song EJ
Anal Bioanal Chem; 2016 Jul; 408(18):4829-33. PubMed ID: 27178549
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of MiR-199b-5p Inducing Differentiation of Bone-Marrow Mesenchymal Stem Cells (BMSCs) Toward Cardiomyocyte-Like Cells via HSF1/HSP70 Pathway.
Dai F; Du P; Chang Y; Ji E; Xu Y; Wei C; Li J
Med Sci Monit; 2018 May; 24():2700-2710. PubMed ID: 29715263
[TBL] [Abstract][Full Text] [Related]
13. Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo.
Su YL; Swiderski P; Marcucci G; Kortylewski M
Methods Mol Biol; 2019; 1974():141-150. PubMed ID: 31099000
[TBL] [Abstract][Full Text] [Related]
14. miR-25 Tough Decoy Enhances Cardiac Function in Heart Failure.
Jeong D; Yoo J; Lee P; Kepreotis SV; Lee A; Wahlquist C; Brown BD; Kho C; Mercola M; Hajjar RJ
Mol Ther; 2018 Mar; 26(3):718-729. PubMed ID: 29273502
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA Expression Is Altered in an Ovalbumin-Induced Asthma Model and Targeting miR-155 with Antagomirs Reveals Cellular Specificity.
Plank MW; Maltby S; Tay HL; Stewart J; Eyers F; Hansbro PM; Foster PS
PLoS One; 2015; 10(12):e0144810. PubMed ID: 26693910
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Silencing of MicroRNA-132 Reduces Blood Glucose and Improves Insulin Secretion.
Bijkerk R; Esguerra JLS; Ellenbroek JH; Au YW; Hanegraaf MAJ; de Koning EJ; Eliasson L; van Zonneveld AJ
Nucleic Acid Ther; 2019 Apr; 29(2):67-72. PubMed ID: 30672723
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S
Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.
Kardani A; Yaghoobi H; Alibakhshi A; Khatami M
J Cell Physiol; 2020 Oct; 235(10):6887-6895. PubMed ID: 32003016
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.
Cristóbal I; Caramés C; Rincón R; Manso R; Madoz-Gúrpide J; Torrejón B; González-Alonso P; Rojo F; García-Foncillas J
Oncotarget; 2017 Jun; 8(25):40169-40180. PubMed ID: 27517624
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-199b promotes the acute spinal cord injury through IKKβ-NF-κB signaling pathway activating microglial cells.
Zhou HJ; Wang LQ; Xu QS; Fan ZX; Zhu Y; Jiang H; Zheng XJ; Ma YH; Zhan RY
Exp Cell Res; 2016 Nov; 349(1):60-67. PubMed ID: 27693495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
